Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.
暂无分享,去创建一个
Stijn Vansteelandt | Johan Decruyenaere | Pieter Depuydt | Elie Azoulay | Maarten Bekaert | S. Vansteelandt | Maarten Bekaert | C. Clec’h | J. Decruyenaere | J. Timsit | É. Azoulay | M. Garrouste-Orgeas | D. Benoit | A. Vésin | Maité Garrouste-Orgeas | Dominique Benoit | P. Depuydt | Jean-Francois Timsit | Christophe Clec'h | Aurélien Vésin
[1] S. Vansteelandt,et al. Reply to Wolkewitz et al. , 2010, Intensive Care Medicine.
[2] J. Rello,et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units , 2009, Critical care medicine.
[3] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[4] M Schumacher,et al. Attributable Mortality due to Nosocomial Infections , 2007, Methods of Information in Medicine.
[5] S. Chevret,et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. , 1996, American journal of respiratory and critical care medicine.
[6] R. Prentice. Observational studies, clinical trials, and the women’s health initiative , 2007, Lifetime data analysis.
[7] James M. Robins,et al. Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease , 2008, Epidemiology.
[8] Jonathan AC Sterne,et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study , 2005, The Lancet.
[9] K. Peter,et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. , 2002, American journal of respiratory and critical care medicine.
[10] A Bueno-Cavanillas,et al. Influence of nosocomial infection on mortality rate in an intensive care unit , 1994, Critical care medicine.
[11] A note on statistical association and causality derived from epidemiological ICU data , 2010, Intensive Care Medicine.
[12] M. Rué,et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. , 1997, Critical care medicine.
[13] Jin Tian,et al. Probabilities of causation: Bounds and identification , 2000, Annals of Mathematics and Artificial Intelligence.
[14] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[15] J. Carlet. Dying from or with a nosocomial pneumonia in the intensive care unit? , 2001, Critical care medicine.
[16] S. Walter. The estimation and interpretation of attributable risk in health research. , 1976, Biometrics.
[17] M. Rovers,et al. Ventilator‐associated pneumonia and mortality: A systematic review of observational studies * , 2009, Critical care medicine.
[18] R. Hotchkiss,et al. Immunotherapy for sepsis--a new approach against an ancient foe. , 2010, The New England journal of medicine.
[19] Elie Azoulay,et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models , 2010, Intensive Care Medicine.
[20] Martin Schumacher,et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models , 2008, Critical care.
[21] S. Chevret,et al. Evaluating mortality in intensive care units: contribution of competing risks analyses , 2005, Critical care.
[22] J. Muscedere. Ventilator-associated pneumonia and mortality: the controversy continues. , 2009, Critical care medicine.
[23] J. Satagopan,et al. A note on competing risks in survival data analysis , 2004, British Journal of Cancer.
[24] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[25] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.
[26] Sanjay Saint,et al. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.
[27] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[28] A. Harris,et al. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. , 2005, American journal of respiratory and critical care medicine.
[29] S. Greenland. Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias , 2003, Epidemiology.
[30] M. Schumacher,et al. Modeling the effect of time-dependent exposure on intensive care unit mortality , 2009, Intensive Care Medicine.
[31] S. Vansteelandt,et al. Adjusting for time-varying confounding in the subdistribution analysis of a competing risk , 2010, Lifetime data analysis.
[32] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[33] Marin H Kollef,et al. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] M. Herridge. Building consensus on ICU-acquired weakness , 2008, Intensive Care Medicine.